The fact that missense mutations in Duox2 in VEO-IBD patients results in an increased invasiveness of bacteria suggests that the upregulation of this enzyme during inflammation is an attempt to contain dysbiosis (Hayes et al., 2015). Here, DUOX2 is linked to inflammatory bowel disease.